Loading...
Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer
BACKGROUND: Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation s...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7069205/ https://ncbi.nlm.nih.gov/pubmed/32164585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6693-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|